Membrane Chromatography Market Size
Study Period | 2018 - 2028 |
Market Size (2023) | USD 272.08 Million |
Market Size (2028) | USD 571.46 Million |
CAGR (2023 - 2028) | 16.00 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Membrane Chromatography Market Analysis
The Membrane Chromatography Market size is expected to grow from USD 272.08 million in 2023 to USD 571.46 million by 2028, at a CAGR of 16% during the forecast period (2023-2028).
The COVID-19 pandemic affected the market. Due to lockdowns and supply chain issues related to the chromatographs, the market was adversely affected during the initial phase. However, initiatives by key market players are expected to increase market growth. For instance, in December 2022, Shimadzu entered into a collaboration with the University Medical Center Göttingen, Germany. The collaboration will focus on the development of new clinical laboratory methods using liquid chromatography-mass spectrometry for therapeutic drug monitoring (TDM) analysis. Thus, such collaborations are expected to increase market growth.
Membrane chromatography is a well-established technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors and in polishing steps for the removal of DNA, host cell protein impurities (HCP), and viruses. The increasing demand for biopharmaceuticals and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are the major factors for the growth of this market. There has been an increase in the acceptance of biopharmaceuticals in recent times. Several key market players have been obtaining approvals from regulatory organizations for biopharmaceutical manufacturing and supply for various disease treatments. For instance, in October 2022, 3P Biopharmaceuticals received approval from the United States Food and Drug Administration (USFDA) that the 3P facilities were acceptable for the manufacture of the target molecule and appropriate for commercialization in the United States once the product is authorized by USFDA. Moreover, the increase in R&D spending in the biopharmaceutical sector aided in the growth of the market. For example, according to ‘The Pharmaceutical Industry and Global Health Facts and Figures 2021' published by the International Federation of Pharmaceutical Manufacturers & Associations, the annual research and development spending of the biopharmaceutical industry has been 7.3 times greater than that of the aerospace and defense, industries, 6.5 times more than that the chemicals industry, and 1.5 times more than that of the software and computer services industry. As per the report, in 2022, over 202 billion was estimated to be spent around the world in biopharmaceutical research and development. The large investments in the market are considered a result of the rising acceptance of biopharmaceuticals over the years.
However, the limited use of membrane chromatography in large-scale manufacturing is expected to restrain the growth of this market during the forecast period.
Membrane Chromatography Market Trends
This section covers the major market trends shaping the Membrane Chromatography Market according to our research experts:
Ion Exchange Membrane Chromatography is Expected to Cover a Large Share of the Market
Ion-exchange chromatography (IC) is a chromatography process that separates ions and polar molecules based on their affinity to the ion exchanger. It works on almost any kind of charged molecule, including large proteins, small nucleotides, and amino acids.
There has been a growing interest in the application of IC in the analysis of pharmaceutical drugs. IC is used in different aspects of product development and quality control testing. In one scuh example, IC is used to improve stabilities and solubility properties of pharmaceutical active drugs molecules as well as used to detect systems that have higher tolerance for organic solvents.IC is also widely used for detection and quantification of excipients or inactive ingredients used in pharmaceutical formulations.
The large share of this segment has been attributed to its wide applications in antibody polishing and virus purification due to the advantages associated with ion exchange membrane chromatography, such as scalability, robustness, disposable nature, high throughput, rapid processing, reduced buffer consumption, and a validation-free environment.
North America is Expected to Dominate the Membrane Chromatography Market
North America includes the United States (US), Canada and Mexico. The US and Canada have well structured and development healthcare systems. These countries also promote pharmaceutical research and development and hence have very high expenditure on healthcare. As a result of these policies, many companies globally are encouraged to operate in this region.
Many of the global pharmaceutical players have their headquarters and research labs in the US. As pharmaceutical research requires membrane chromatography, the demand for these technologies and processes is high is North America.This large share can be attributed to the increasing demand for biopharmaceuticals and rising R&D expenditure by biopharmaceutical companies in North America.
Membrane Chromatography Industry Overview
The majority of the membrane chromatography technique and processe instruments are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.
Membrane Chromatography Market Leaders
3M
Thermo Fisher Scientific
Merck KGaA
Danaher Corporation
Sartorius AG
*Disclaimer: Major Players sorted in no particular order
Membrane Chromatography Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Demand for Biopharmaceuticals
-
4.2.2 Increasing Regulatory Scrutiny on the Cleaning Validation of Downstream Purification Processes
-
4.2.3 Increasing R&D Expenditure in the Biopharmaceutical Industry
-
-
4.3 Market Restraints
-
4.3.1 Limited Use of Membrane Chromatography Products in Large-Scale Manufacturing
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 Capsules & Cartridges
-
5.1.2 Syringe Filters
-
5.1.3 Membrane Filters
-
5.1.4 Filter Plates
-
5.1.5 Spin Columns
-
5.1.6 Others Consumables and Accessories
-
-
5.2 By Technique
-
5.2.1 Ion Exchange Membrane Chromatography
-
5.2.2 Affinity Membrane Chromatography
-
5.2.3 Hydrophobic Interaction Membrane Chromatography (HIMC)
-
-
5.3 Geography
-
5.3.1 North America
-
5.3.1.1 United States
-
5.3.1.2 Canada
-
5.3.1.3 Mexico
-
-
5.3.2 Europe
-
5.3.2.1 Germany
-
5.3.2.2 United Kingdom
-
5.3.2.3 France
-
5.3.2.4 Italy
-
5.3.2.5 Spain
-
5.3.2.6 Rest of Europe
-
-
5.3.3 Asia-Pacific
-
5.3.3.1 China
-
5.3.3.2 Japan
-
5.3.3.3 India
-
5.3.3.4 Australia
-
5.3.3.5 South Korea
-
5.3.3.6 Rest of Asia-Pacific
-
-
5.3.4 Middle-East and Africa
-
5.3.4.1 GCC
-
5.3.4.2 South Africa
-
5.3.4.3 Rest of Middle-East and Africa
-
-
5.3.5 South America
-
5.3.5.1 Brazil
-
5.3.5.2 Argentina
-
5.3.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 3M
-
6.1.2 Asahi Kasei
-
6.1.3 Cole-Parmer
-
6.1.4 Danaher Corporation
-
6.1.5 GE Healthcare
-
6.1.6 Membrane Solutions
-
6.1.7 Merck KGaA
-
6.1.8 Purilogics
-
6.1.9 Sartorius AG
-
6.1.10 Thermo Fisher Scientific
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Membrane Chromatography Industry Segmentation
Membrane chromatography is a technology in bioprocessing that is routinely used in the capture of large particles such as viruses and viral vectors, as well as in polishing steps for the removal of DNA, HCPs and virus.
By Product | |
Capsules & Cartridges | |
Syringe Filters | |
Membrane Filters | |
Filter Plates | |
Spin Columns | |
Others Consumables and Accessories |
By Technique | |
Ion Exchange Membrane Chromatography | |
Affinity Membrane Chromatography | |
Hydrophobic Interaction Membrane Chromatography (HIMC) |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Membrane Chromatography Market Research FAQs
How big is the Membrane Chromatography Market?
The Membrane Chromatography Market size is expected to reach USD 272.08 million in 2023 and grow at a CAGR of 16% to reach USD 571.46 million by 2028.
What is the current Membrane Chromatography Market size?
In 2023, the Membrane Chromatography Market size is expected to reach USD 272.08 million.
Who are the key players in Membrane Chromatography Market?
3M, Thermo Fisher Scientific, Merck KGaA, Danaher Corporation and Sartorius AG are the major companies operating in the Membrane Chromatography Market.
Which is the fastest growing region in Membrane Chromatography Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2022-2028).
Which region has the biggest share in Membrane Chromatography Market?
In 2022, the North America accounts for the largest market share in Membrane Chromatography Market.
Membrane Chromatography Industry Report
Statistics for the 2023 Membrane Chromatography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Membrane Chromatography analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.